Carnitine-Related Alterations in Patients With Intermittent Claudication
- 1 May 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (9) , 1685-1689
- https://doi.org/10.1161/01.cir.93.9.1685
Abstract
Background Carnitine metabolism is altered in peripheral arterial disease. l -carnitine supplementation may correct these alterations and improve walking performance. Methods and Results Plasma levels of carnitine and its esters were measured at rest and after maximally tolerated exercise in 22 claudicant patients and 8 normal subjects. One week later, this protocol was repeated in patients after random administration of placebo or l -carnitine (500 mg IV as a single bolus). Two groups of patients emerged. In 10 patients (group IC1), the plasma level of acetylcarnitine at rest was 3.7±0.2 μmol/L and increased significantly ( P <.01) at maximally tolerated exercise. In 12 patients (group IC2), the resting level of plasma acetylcarnitine was elevated (7.9±0.7 μmol/L, P <.01) and decreased with exercise. Furthermore, group IC2 patients had a significantly lower walking capacity than group IC1 patients. In both groups, placebo did not affect the metabolic profile, nor did it improve exercise performance. Conversely, after l -carnitine administration, all but one patient in group IC2 (n=7) showed an increase in plasma acetylcarnitine concentration during exercise versus the decrease observed without l -carnitine. This metabolic effect was accompanied by a significant increase ( P <.01) in walking capacity. Interestingly, in group IC1 patients (n=5), l -carnitine neither improved walking capacity nor modified the metabolic profile. Statistical analysis showed that changes in walking capacity with l -carnitine treatment were influenced exclusively by exercise-induced changes in plasma acetylcarnitine. Conclusions In patients with intermittent claudication, assessment of plasma acetylcarnitine at rest and after exercise may be a means to select a target population for l -carnitine therapy.Keywords
This publication has 21 references indexed in Scilit:
- Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions.Journal of Clinical Investigation, 1994
- Conservative Management of Intermittent ClaudicationAnnals of Internal Medicine, 1990
- Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state.Journal of Clinical Investigation, 1989
- Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondriaMuscle & Nerve, 1988
- CARNITINEAnnual Review of Biochemistry, 1988
- Another Look at the Pentoxifylline Efficacy Data for Intermittent ClaudicationThe Journal of Clinical Pharmacology, 1987
- [28] Short-chain acylcarnitines: Identification and quantitationPublished by Elsevier ,1986
- [27] Radioisotopic assay of acetylcarnitine and acetyl-CoAPublished by Elsevier ,1986
- Urinary Excretion of l-Carnitine and Acylcarnitines by Patients with Disorders of Organic Acid Metabolism: Evidence for Secondary Insufficiency of l-CarnitinePediatric Research, 1984
- Relationship between acid-soluble carnitine and coenzyme A pools in vivoBiochemical Journal, 1980